Insights

European expansion The company is actively growing its European footprint with new senior hires focused on Southern Europe, the Netherlands, and other European markets, signaling readiness for regional partnerships and co-development opportunities.

Leadership growth Recent appointments across commercial, business development and quality leadership indicate a strategic push to scale client relationships, regulatory footprint, and global sell-through; target firms should align through multi-tier engagement.

Clinical to commercial ramp Core capability in rapid sterile fill/finish for clinical trial materials and commercial products, including complex biologics and gene therapy vectors, presents a strong value proposition for sponsors needing fast, compliant manufacturing scale-up.

Global compliance focus MHRA-licensed and FDA-approved facilities underscore high regulatory standards; potential clients moving programs across regions should be prioritized for CDMO partner discussions on regulatory readiness and quality excellence.

Diverse modality readiness Capabilities to handle antibodies, proteins, nucleic acids, cytotoxic APIs, ADCs, and small molecules suggest opportunities with biopharma and pharma companies pursuing integrated fill/finish for mixed modality portfolios.

Similar companies to Symbiosis Pharmaceutical Services

Symbiosis Pharmaceutical Services Tech Stack

Symbiosis Pharmaceutical Services uses 8 technology products and services including Canva, WordPress, Microsoft 365, and more. Explore Symbiosis Pharmaceutical Services's tech stack below.

Media & News

Symbiosis Pharmaceutical Services's Email Address Formats

Symbiosis Pharmaceutical Services uses at least 3 email formats:
Symbiosis Pharmaceutical Services Email FormatsExamplePercentage
First.Last@symbiosis-pharma.comJohn.Doe@symbiosis-pharma.com
98%
First@symbiosis-pharma.comJohn@symbiosis-pharma.com
1%
LastF@symbiosis-pharma.comDoeJ@symbiosis-pharma.com
1%

Frequently Asked Questions

What is Symbiosis Pharmaceutical Services's phone number?

Minus sign iconPlus sign icon
You can contact Symbiosis Pharmaceutical Services's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Symbiosis Pharmaceutical Services's official website and social media links?

Minus sign iconPlus sign icon
Symbiosis Pharmaceutical Services's official website is symbiosis-pharma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Symbiosis Pharmaceutical Services generate?

Minus sign iconPlus sign icon
As of October 2026, Symbiosis Pharmaceutical Services's annual revenue is estimated to be $10M - $25M.

What is Symbiosis Pharmaceutical Services's SIC code and NAICS code?

Minus sign iconPlus sign icon
Symbiosis Pharmaceutical Services's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Symbiosis Pharmaceutical Services have currently?

Minus sign iconPlus sign icon
As of October 2026, Symbiosis Pharmaceutical Services has approximately 138 employees across 3 continents, including Europe, Asia and North America. Key team members include Chief Operating Officer: D. M., Chief Operating Officer (coo): J. M. and Chief Commercial Officer: J. A. Explore Symbiosis Pharmaceutical Services's employee directory with LeadIQ.

What industry does Symbiosis Pharmaceutical Services belong to?

Minus sign iconPlus sign icon
Symbiosis Pharmaceutical Services operates in the Pharmaceutical Manufacturing industry.

What technology does Symbiosis Pharmaceutical Services use?

Minus sign iconPlus sign icon
Symbiosis Pharmaceutical Services's tech stack includes Canva, WordPress, Microsoft 365, Microsoft Dynamics, Google Cloud, Pardot, HubSpot and WP Engine.

What is Symbiosis Pharmaceutical Services's email format?

Minus sign iconPlus sign icon
Symbiosis Pharmaceutical Services's email format typically follows the pattern of First.Last@symbiosis-pharma.com. Find more Symbiosis Pharmaceutical Services email formats with LeadIQ.

How much funding has Symbiosis Pharmaceutical Services raised to date?

Minus sign iconPlus sign icon
As of October 2026, Symbiosis Pharmaceutical Services has raised $2M in funding. The last funding round occurred on Dec 17, 2019 for $2M.

When was Symbiosis Pharmaceutical Services founded?

Minus sign iconPlus sign icon
Symbiosis Pharmaceutical Services was founded in 2011.
Symbiosis Pharmaceutical Services logo

Symbiosis Pharmaceutical Services

Pharmaceutical ManufacturingScotland, United Kingdom51-200 Employees

Symbiosis Pharmaceutical Services is a contract development and manufacturing organisation specialising in GMP sterile fill/finish of injectable products for clinical trials and commercial sales worldwide. It operates in MHRA-licensed and FDA-approved facilities that support aseptic liquid filling and lyophilisation for complex biologics, viral vectors for gene therapies, and small molecule drugs. The company focuses on filling vials with liquids or lyophilised formulations, including antibodies, proteins, peptides, nucleic acids, cytotoxic and highly potent APIs such as ADCs, with an emphasis on regulatory compliance, technical capability, and operational flexibility.

Headquartered in Stirling, Scotland, it aims to provide fast-access manufacturing slots and rapid release of drug product to meet demand across global markets. A notable development in 2025 was the expansion of its facilities in Stirling and the launch of an automated commercial-scale manufacturing line, reflecting its ongoing scale-up and capability enhancements.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2011
Employees
51-200

Section iconFunding & Financials

  • $2M

    Symbiosis Pharmaceutical Services has raised a total of $2M of funding over 3 rounds. Their latest funding round was raised on Dec 17, 2019 in the amount of $2M as a Grant.

  • $10M - $25M

    Symbiosis Pharmaceutical Services's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.